Sartorius Stedim Biotech and US-based Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will aim to support the education and preparation of the next generation of biotech leaders.
Sartorius is an international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. Part of Sartorius’ investment will be to enhance a fermentation facility that will play a significant role in Penn State’s Center of Excellence in Industrial Biotechnology (CoEIB).
O. Richard Bundy III, Penn State’s VP for development and alumni relations, said: “Sartorius is a global leader in research and manufacturing technologies in the field of biotechnology. Their support will enable Penn State to provide an environment that closely matches what is available in today’s premier research and manufacturing facilities, further elevating the university’s leadership position in this rapidly growing field.”
Sartorius, together with additional industry partners, has been supporting Penn State for more than a year in designing the new lab space and in equipping it based on the latest technologies.
The fermentation facility is one of ten core facilities in the Huck Institutes of the Life Sciences and the cornerstone of Penn State’s comprehensive biotechnology effort.
The CoEIB provides a focal point for Penn State’s programmes in the area of industrial biotechnology, including the development of research and educational initiatives focused, among other areas, on biopharmaceutical manufacturing.
Reinhard Vogt, member of the executive committee of Sartorius Stedim Biotech, commented: “The innovative bioanalytical and bioprocess technologies of Sartorius will enable these scientists to accelerate progress in biotechnology.”